Forefront Analytics, LLC — 13F Holdings & Portfolio

CIK 1696802 · latest 13F-HR filed 2026-08-13

Forefront Analytics, LLC manages $92.0M in 13F-reported U.S. long-equity assets across 37 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are VWO (11.70%), ESGD (11.65%), ESGE (11.43%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions and exited 2; 23 existing positions rose in reported value and 10 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$92.0M

Long-equity book

Holdings
37

Distinct positions

Period
2026-06-30

Filed 2026-08-13

Q/Q Activity
+0 / −2 / ↑23 / ↓10

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 82.7%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated May 30, 2026.

Assets Under Management
$679.0M
Discretionary
$447.1M
Employees
18
Accounts
339
Address
ONE TOWER BRIDGE
100 FRONT STREET, SUITE 1111
W. CONSHOHOCKEN, PA 19428
Phone
(610) 341-3900
Name Title / Status Ownership Type
Bosacker, Alec, John ControlCHIEF COMPLIANCE OFFICER
since Jan 2023
Less than 5%Individual
GECZY, CHRISTOPHER, CHARLES ControlMANAGING MEMBER/CHIEF EXECUTIVE OFFICER
since Jan 2009
75% or moreIndividual
Ownership & leadership changes · 6 filings with changes since Nov 8, 2011

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Apr 14, 2023 filing
  • No longer listedKITCHING, STEPHEN, RICHARD · CHIEF OPERATIONS OFFICER · Less than 5% · control person · listed since Apr 2008
Jan 20, 2023 filing
  • No longer listedGOLDEN, MAHIN, BOOTH · CHIEF COMPLIANCE OFFICER · Less than 5% · control person · listed since Mar 2022
  • AddedBosacker, Alec, John · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
Mar 29, 2022 filing
  • No longer listedNEILIO, NICHOLAS · CHIEF COMPLIANCE OFFICER · Less than 5% · control person · listed since Nov 2012
  • AddedGOLDEN, MAHIN, BOOTH · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
Mar 29, 2018 filing
  • ChangedGECZY, CHRISTOPHER, CHARLES · title MANAGING MEMBER → MANAGING MEMBER/CHIEF EXECUTIVE OFFICER
May 18, 2017 filing
  • AddedKITCHING, STEPHEN, RICHARD · CHIEF OPERATIONS OFFICER · Less than 5% · control person
Mar 28, 2014 filing
  • AddedNEILIO, NICHOLAS · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
  • ChangedGECZY, CHRISTOPHER, CHARLES · title MANAGING MEMBER / CHIEF COMPLIANCE OFFICER → MANAGING MEMBER
Nov 8, 2011 filing (earliest on record)
  • ListedGECZY, CHRISTOPHER, CHARLES · MANAGING MEMBER / CHIEF COMPLIANCE OFFICER · 75% or more · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Top Adds (vs prior quarter)

Show all 23 →

Top Trims

Show all 10 →

New Positions

  • No new positions this quarter.
Show all 0 →

Forefront Analytics, LLC Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 VANGUARD INTL EQUITY INDEX F VWO 922042858 $10.8M 11.70% 180,376 SH
2 ISHARES TR ESGD 46435G516 $10.7M 11.65% 104,247 SH
3 ISHARES INC ESGE 46434G863 $10.5M 11.43% 192,398 SH
4 ISHARES TR HDV 46429B663 $9.4M 10.21% 342,756 SH
5 ISHARES TR MTUM 46432F396 $8.4M 9.10% 24,434 SH
6 NUSHARES ETF TR NULV 67092P300 $7.0M 7.65% 140,912 SH
7 DBX ETF TR DBEF 233051200 $6.9M 7.52% 126,734 SH
8 FLEXSHARES TR ESGG 33939L688 $5.1M 5.49% 21,669 SH
9 NVIDIA CORPORATION NVDA 67066G104 $3.9M 4.25% 19,532 SH
10 VANGUARD TAX-MANAGED FDS VEA 921943858 $3.4M 3.68% 47,559 SH
11 ISHARES TR IVV 464287200 $3.3M 3.62% 4,450 SH
12 ISHARES INC HEEM 46434G509 $2.6M 2.83% 58,203 SH
13 JPMORGAN CHASE & CO JPM 46625H100 $1.6M 1.78% 4,997 SH
14 DEERE & CO DE 244199105 $743.2K 0.81% 1,172 SH
15 UNITEDHEALTH GROUP INC UNH 91324P102 $585.8K 0.64% 1,409 SH
16 INCYTE CORP INCY 45337C102 $577.1K 0.63% 5,091 SH
17 EDWARDS LIFESCIENCES CORP EW 28176E108 $557.1K 0.61% 6,158 SH
18 PROSHARES TR SSO 74347R107 $551.2K 0.60% 8,180 SH
19 PROSHARES TR UWM 74347R842 $537.7K 0.58% 7,997 SH
20 ABBOTT LABORATORIES ABT 002824100 $514.1K 0.56% 5,665 SH
21 WISDOMTREE TR EES 97717W562 $475.9K 0.52% 7,020 SH
22 PFIZER INC PFE 717081103 $438.5K 0.48% 18,210 SH
23 MEDTRONIC PLC MDT G5960L103 $416.1K 0.45% 5,319 SH
24 DANAHER CORP DEL DHR 235851102 $388.5K 0.42% 2,040 SH
25 THERMO FISHER SCIENTIFIC INC TMO 883556102 $335.6K 0.36% 669 SH
26 BLUE OWL TECHNOLOGY FIN CORP OTF 095924106 $306.9K 0.33% 29,654 SH
27 LEGEND BIOTECH CORP LEGN 52490G102 $305.2K 0.33% 10,568 SH
28 PHILIP MORRIS INTL INC PM 718172109 $264.6K 0.29% 1,463 SH
29 REGENERON PHARMACEUTICALS REGN 75886F107 $258.8K 0.28% 415 SH
30 SCHWAB STRATEGIC TR SCHD 808524797 $243.4K 0.26% 7,676 SH
31 VANGUARD INDEX FDS VTV 922908744 $236.3K 0.26% 1,084 SH
32 ZURA BIO LTD ZURA G9TY5A101 $159.1K 0.17% 26,968 SH
33 GERON CORP GERN 374163103 $113.6K 0.12% 88,779 SH
34 CYTOMX THERAPEUTICS INC. CTMX 23284F105 $93.9K 0.10% 25,033 SH
35 BICYCLE THERAPEUTICS PLC BCYC 088786108 $92.5K 0.10% 21,822 SH
36 NKARTA INC NKTX 65487U108 $81.9K 0.09% 28,955 SH
37 ANNEXON INC ANNX 03589W102 $81.3K 0.09% 14,240 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-13 $92.0M 37 0001085146-26-000598
2026-03-31 2026-05-13 $110.0M 39 0001696802-26-000003
2025-12-31 2026-02-17 $113.3M 47 0001696802-26-000001
2025-09-30 2025-11-21 $103.8M 46 0001696802-25-000003
Filer Information
Address
ONE TOWER BRIDGE
100 FRONT STREET, SUITE 1111
WEST CONSHOHOCKEN, PA 19428
Phone
(610) 341-3900
Filing Manager
Forefront Analytics, LLC
WEST CONSHOHOCKEN, PA
Signatory
Alec Bosacker
Chief Compliance Officer